[EN] CYCLOSPORINE COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSITIONS DE CYCLOSPORINE ET MÉTHODES D'UTILISATION
申请人:BACAINN THERAPEUTICS INC
公开号:WO2020041378A1
公开(公告)日:2020-02-27
Disclosed herein are cyclosporine compounds and methods for use in the treatment or prevention of neutrophil-mediated inflammation, wherein the compounds inhibit the activity of MRP2 and FPR1.